Showing results (1261-1270 of 2,877) with videos related to

Sort By:
Pageof 288
Molecular Diversity|January 21, 2014
Recent progress on fluorous synthesis of biologically interesting compoundsZhong-Xing Jiang, Sanjun Zhi, Wei Zhang
Molecular Diversity|October 24, 2012
De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein-ligand interaction fingerprint, and ADMET predictionYanmin Zhang, Haichun Liu, Yu Jiao, et al.
Molecular Diversity|August 15, 2025
Druggability assessments of small peptides as protein-protein interaction inhibitors targeting EED-EZH2 binding within the Polycomb Repressive Complex 2 (PRC2), an epigenetic regulatorVarun Thachan Kundil, Sharanya C Suresh, Sreeja Chellappan, et al.
Molecular Diversity|August 15, 2025
Asymmetric C2-functionalization of indoles via visible-light-promoted three-component reactionHan-Peng Pan, Xiao-Ying Hu, Jun-Hui Luo, et al.
Molecular Diversity|August 13, 2025
Design, synthesis and SARS-CoV‑2 main protease inhibitory activities of 2-arylthiomethyl-6-bromoindole derivativesZong Xinyu, Li Xiaoyang, Liu Shiyu, et al.
Molecular Diversity|November 12, 2025
LKE-DTA: predicting drug-target binding affinity with large language model representations and knowledge graph embeddingsJielong Mou, Yudong Yan, Boren Jiang, et al.
Molecular Diversity|November 12, 2025
A potent and selective PROTAC degrader of CDK9 as effective inhibitor of HIV-1 RNA synthesisBo Yang, Ling Ma, Xiaotang Yang, et al.
Molecular Diversity|October 23, 2025
Novel 1,2,4-oxadiazole derivatives containing a sulfone moiety: Design, synthesis, biological activity, and antivirulence factorsZongnan Zhu, Xing Liu, Yue Zou, et al.
Molecular Diversity|July 19, 2025
An innovative machine learning-based QSAR approach for prediction and structural analysis of novel/repurposed acid ceramidase (ASAH1) inhibitors for glioblastoma therapyHarshit Sajal, Seema Mishra
Molecular Diversity|July 19, 2025
Design, synthesis, and biological evaluation of aminopyrazine-based ATR/HDACs dual inhibitorsYing-Hui Yuan, Chen-Chen Wang, Ji-Long Duan, et al.
Pageof 288